OTLK Outlook Therapeutics, Inc.
Price Chart
Executive Summary
Two directors at Outlook Therapeutics made open-market purchases totaling ~$179K on May 26, 2026, just 13 days after the company filed an at-the-market (ATM) offering agreement for up to $100M in common stock. Director Kurt J. Hilzinger bought 400,000 shares ($177K) and Director Randy H. Thurman bought 5,000 shares ($2K). The purchases represent ~0.37% of the company's $48M market cap — a notable insider vote of confidence given the massive dilution overhang from the recently disclosed ATM facility.
Key Financial Metrics
Actionable Insight
Directors buying shortly after a massive ATM filing signals confidence that management views the current market cap as undervalued despite the massive dilution overhang. However, the $100M ATM overhanging the stock could pressure the float for months. Monitor subsequent insider activity and any Form 4 filings — continued buying by C-suite executives would be a stronger signal than these two director purchases. The 33% historical win rate on OTLK reports warrants caution on the bullish thesis.
Key Facts
- Director Kurt J. Hilzinger purchased 400,000 shares at ~$0.44/share for $177K on 2026-05-26
- Director Randy H. Thurman purchased 5,000 shares at ~$0.43/share for $2K on 2026-05-26
- Total open-market insider purchases: ~$179K, representing ~0.37% of $48M market cap
- Purchases occurred 13 days after filing an ATM offering agreement for up to $100M in common stock (filed 2026-05-13)
- Stock closed at $0.2425 on 2026-05-12 prior to ATM filing; purchases at ~$0.44 suggest a more than 80% appreciation in two weeks
- No insider sales were detected in this cluster window
Financial Impact
~$179K in insider purchases, or ~0.37% of market cap
Risk Factors
- ATM facility allows sales up to $100M — ~208% of current market cap — creating severe potential dilution
- Historical model calibration shows only 30-32% of score-5/6 reports on this filing type moved up at T+20
- Only non-C-suite directors purchased; CEO/CFO have not bought and may have sold via ATM
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-OTLK-1779909681916 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 16, 2026
today
|
8-K
| $1.18 awaiting T+5 | awaiting T+5 | — | $1.57 (+33.05%) |
|
Jun 16, 2026
today
|
Press Release
| $1.17 awaiting T+5 | awaiting T+5 | — | $1.57 (+34.19%) |
|
Jun 3, 2026
13d ago
|
Insider Cluster
| $0.7950 $1.10 | ▲ +38.36% | ▲ +40.92% | $1.57 (+97.48%) |
|
Jun 2, 2026
15d ago
|
Insider Cluster
| $0.8140 $0.7050 | ▼ −13.39% | ▼ −10.43% | $1.57 (+92.87%) |
|
Jun 1, 2026
15d ago
|
DEFA14A
| $0.8140 $0.7050 | ▲ +13.39% | ▲ +10.43% | $1.57 (−92.87%) |
|
Jun 1, 2026
15d ago
|
8-K
| $0.8430 $0.7770 | ▼ −7.83% | ▼ −5.08% | $1.57 (+86.24%) |
|
May 29, 2026
18d ago
|
8-K
| $0.8430 $0.7770 | ▲ +7.83% | ▲ +5.08% | $1.57 (−86.24%) |
|
May 29, 2026
18d ago
|
424B5
| $0.7300 $0.8100 | ▼ −10.96% | ▼ −11.25% | $1.57 (−115.07%) |
|
May 28, 2026
19d ago
|
8-K
| $0.7300 $0.8100 | ▼ −10.96% | ▼ −11.25% | $1.57 (−115.07%) |
|
May 28, 2026
19d ago
|
Press Release
| $0.7300 $0.8100 | ▼ −10.96% | ▼ −11.25% | $1.57 (−115.07%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access